Citation: J. Simova et al., IRRADIATED IL-2 GENE-MODIFIED PLASMACYTOMA VACCINES ARE MORE EFFICIENT THAN LIVE VACCINES, International journal of oncology, 12(5), 1998, pp. 1195-1198
Authors:
INDROVA M
BUBENIK J
ROSSNER P
ZEUTHEN J
JANDLOVA T
SOBOTA V
Citation: M. Indrova et al., IMMUNOGENICITY, IMMUNOSENSITIVITY AND CELL-SURFACE ADHESIVENESS OF TUMOR VACCINES CARRYING AN INSERTED CD80 GENE, International journal of oncology, 12(2), 1998, pp. 387-390
Authors:
VLK V
ROSSNER P
INDROVA M
BUBENIK J
SOBOTA V
Citation: V. Vlk et al., INTERLEUKIN-2 GENE-THERAPY OF SURGICAL MINIMAL RESIDUAL TUMOR DISEASE, International journal of cancer, 76(1), 1998, pp. 115-119
Authors:
BUBENIK J
ROSSNER P
BUBENIKOVA D
SIMOVA J
INDROVA M
SLONCOVA E
Citation: J. Bubenik et al., TUMOR VACCINES EXPRESSING IL-2, CD80, AND IL-2 PLUS CD80 GENE, International journal of oncology, 11(6), 1997, pp. 1213-1219
Authors:
ROSSNER P
BUBENIK J
INDROVA M
SOBOTA V
VONDRYS P
ZEUTHEN J
JANDLOVA T
TAKAC M
Citation: P. Rossner et al., GENETICALLY-MODIFIED TUMOR VACCINES - INSERTION OF THE IL-2 GENE DOWN-REGULATES TUMORIGENICITY MORE EFFICIENTLY THAN INSERTION OF THE CD80 GENE, International journal of oncology, 10(1), 1997, pp. 77-82
Authors:
SOBOTA V
BUBENIK J
INDROVA M
VLK V
JAKOUBKOVA J
Citation: V. Sobota et al., USE OF CRYOPRESERVED LYMPHOCYTES FOR ASSESSMENT OF THE IMMUNOLOGICAL EFFECTS OF INTERFERON THERAPY IN RENAL-CELL CARCINOMA PATIENTS, Journal of immunological methods, 203(1), 1997, pp. 1-10
Authors:
INDROVA M
BUBENIK J
JAKOUBKOVA J
SOBOTA V
HELMICHOVA E
SIMOVA J
Citation: M. Indrova et al., IFN-ALPHA THERAPY OF RENAL-CELL CARCINOMA - DEFECT OF LYMPHOCYTE SENSITIVITY TO MITOGENIC AND ACTIVATING CYTOKINE SIGNALS IN PATIENTS NOT-RESPONDING TO THERAPY, International journal of oncology, 7(3), 1995, pp. 523-526
Authors:
BUBENIK J
SIMOVA J
BUBENIKOVA D
ZEUTHEN J
INDROVA M
Citation: J. Bubenik et al., INTERLEUKIN-2 GENE-THERAPY OF RESIDUAL EL-4 LEUKEMIA POTENTIATES THE EFFECT OF CYCLOPHOSPHAMIDE PRETREATMENT, Journal of cancer research and clinical oncology, 121(1), 1995, pp. 39-43
Authors:
BUBENIK J
ZEUTHEN J
INDROVA M
BUBENIKOVA D
SIMOVA J
Citation: J. Bubenik et al., KINETICS AND FUNCTION OF PERITONEAL-EXUDATE CELLS DURING LOCAL IL-2 GENE-THERAPY OF CANCER, International journal of oncology, 4(1), 1994, pp. 13-16
Authors:
INDROVA M
BUBENIK J
JAKOUBKOVA J
SIMOVA J
JANDLOVA T
HELMICHOVA E
BENESOVA K
HESOVA M
STAHALOVA V
Citation: M. Indrova et al., SUBCUTANEOUS INTERLEUKIN-2 IN COMBINATION WITH VINBLASTINE FOR METASTATIC RENAL-CANCER - CYTOLYTIC ACTIVITY OF PERIPHERAL-BLOOD LYMPHOCYTES, Neoplasma, 41(4), 1994, pp. 197-200
Authors:
ABRONINA IF
INDROVA M
BUBENIC J
FIGURIN KM
MALAKHOVA NV
BYKOVSKAYA SN
Citation: If. Abronina et al., THE INFLUENCE OF TUMOR-IMMUNITY SUPPRESSORS ON THE EFFECTOR STAGE OF HUMAN AND ANIMAL LYMPHOKINE-ACTIVATED KILLER-CELLS, Biomedicine & pharmacotherapy, 47(9), 1993, pp. 371-377
Authors:
SIMOVA J
BUBENIK J
INDROVA M
BUBENIKOVA D
JANDLOVA T
Citation: J. Simova et al., THERAPEUTIC EFFICACY OF REPEATED CYCLES OF LOCAL IL-2 INJECTIONS IN MICE CARRYING SLOWLY GROWING TUMOR GRAFTS, Folia biologica, 39(6), 1993, pp. 315